A study investigating the validity of modified Tokuhashi score to decide surgical intervention in patients with metastatic spinal cancer
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F13%3A43906593" target="_blank" >RIV/00216208:11120/13:43906593 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1007/s00586-012-2480-z" target="_blank" >http://dx.doi.org/10.1007/s00586-012-2480-z</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00586-012-2480-z" target="_blank" >10.1007/s00586-012-2480-z</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
A study investigating the validity of modified Tokuhashi score to decide surgical intervention in patients with metastatic spinal cancer
Popis výsledku v původním jazyce
Predicted survival of a patient is the most important parameter that helps to guide the treatment of a patient with metastatic spinal cancer. We aimed to investigate the reliability of modified Tokuhashi score in the decision-making process in patients with metastatic spinal cancer. METHODS: We performed a review of our prospectively collected Metastatic Cancer Database over a period of 4 years (2007-2010). Ninety consecutive patients who were treated for metastatic spinal cancer were enrolled. Data review included demographic details, source of primary cancer, duration of symptoms, location of metastases, calculated Karnofsky's performance status, and calculated survival based on modified Tokuhashi score. We divided the patients into 3 groups. Group Aincluded patients with expected survival less than 6 months. Group B included patients with expected survival between 6 and 12 months. Group C included patients whose expected survival was more than 12 months. We compared the calculated
Název v anglickém jazyce
A study investigating the validity of modified Tokuhashi score to decide surgical intervention in patients with metastatic spinal cancer
Popis výsledku anglicky
Predicted survival of a patient is the most important parameter that helps to guide the treatment of a patient with metastatic spinal cancer. We aimed to investigate the reliability of modified Tokuhashi score in the decision-making process in patients with metastatic spinal cancer. METHODS: We performed a review of our prospectively collected Metastatic Cancer Database over a period of 4 years (2007-2010). Ninety consecutive patients who were treated for metastatic spinal cancer were enrolled. Data review included demographic details, source of primary cancer, duration of symptoms, location of metastases, calculated Karnofsky's performance status, and calculated survival based on modified Tokuhashi score. We divided the patients into 3 groups. Group Aincluded patients with expected survival less than 6 months. Group B included patients with expected survival between 6 and 12 months. Group C included patients whose expected survival was more than 12 months. We compared the calculated
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FJ - Chirurgie včetně transplantologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2013
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
European Spine Journal
ISSN
0940-6719
e-ISSN
—
Svazek periodika
22
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
4
Strana od-do
565-568
Kód UT WoS článku
000315602300015
EID výsledku v databázi Scopus
—